Oramed Pharmaceuticals Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY	FY
Period Ending	Mar '26 Mar 11, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Aug '21 Aug 31, 2021	Aug '20 Aug 31, 2020
Market Cap	408	300	290	1,479	2,158	257
Market Cap Growth	31.04%	3.67%	-80.42%	-31.48%	740.62%	43.17%
Enterprise Value	-6.89	-143.19	-57.28	994.92	1,869	132.85
PE Ratio	2.81	-5.04	16.50	-12.80	-25.23	-6.23
PS Ratio	61.64	-	69.54	176.08	256.97	30.49
PB Ratio	0.61	0.66	0.57	3.14	6.00	2.51
P/TBV Ratio	205.48	0.68	0.57	3.09	4.84	2.18
P/FCF Ratio	-	-11.46	-8.83	-16.75	-32.22	-6.60
P/OCF Ratio	-	-11.48	-9.05	-17.05	-32.79	-6.64
EV/Sales Ratio	-	-	-13.76	118.47	222.56	15.78
EV/EBITDA Ratio	-	3.66	1.18	-7.90	24.76	3.63
EV/EBIT Ratio	-	3.61	1.17	-7.89	24.84	3.64
EV/FCF Ratio	0.20	5.47	1.75	-11.27	-27.91	-3.41
Debt / Equity Ratio	0.00	0.00	0.32	0.00	0.00	0.00
Debt / EBITDA Ratio	-0.08	-0.03	-3.31	-0.02	0.02	0.01
Debt / FCF Ratio	-0.07	-0.04	-4.89	-0.03	-0.02	-0.01
Net Debt / Equity Ratio	-0.66	-0.97	-0.67	-1.02	-0.81	-1.21
Net Debt / EBITDA Ratio	13.11	11.25	7.09	3.82	-3.85	-3.38
Net Debt / FCF Ratio	11.56	16.79	10.47	5.45	4.34	3.18
Asset Turnover	-	0	0.01	0.02	0.03	0.07
Quick Ratio	22.01	24.97	3.05	27.10	14.09	8.80
Current Ratio	22.24	25.19	3.06	27.34	14.27	8.93
Return on Equity (ROE)	-5.35%	-12.39%	3.24%	-28.22%	30.78%	44.04%
Return on Assets (ROA)	2.63%	-5.44%	-8.25%	-27.96%	28.06%	29.65%
Return on Invested Capital (ROIC)	11.10%	-31.41%	-53.76%	-254.41%	146.36%	818.16%
Return on Capital Employed (ROCE)	-5.68%	-8.07%	-9.76%	-29.29%	30.01%	33.86%
Earnings Yield	35.57%	-19.83%	6.06%	-7.81%	-3.96%	-16.05%
FCF Yield	-8.61%	-8.73%	-11.32%	-5.97%	-3.10%	-15.15%
Buyback Yield / Dilution	1.79%	2.57%	-2.61%	-2.26%	-14.60%	-28.79%

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.